This inventor holds 2 USPTO granted patents. Top assignee: Genentech, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations by Xi Chen in Biopharmaceuticals
Introduction
Xi Chen is an accomplished inventor based in South San Francisco, CA. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative treatments for various diseases. His work is characterized by a focus on bispecific antibodies, which have the potential to revolutionize therapeutic approaches.
Latest Patents
Xi Chen holds a patent titled "Dosing for Treatment with Anti-CD20/Anti-CD3 Bispecific Antibodies and Anti-CD79B Antibody Drug Conjugates." This patent represents a crucial advancement in the treatment of conditions that require targeted therapies, showcasing his expertise in antibody drug conjugates.
Career Highlights
Xi Chen is currently employed at Genentech, Inc., a leading biotechnology company known for its commitment to developing innovative medicines. His role at Genentech allows him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to biopharmaceutical research.
Collaborations
Throughout his career, Xi Chen has worked alongside talented colleagues, including Brendan Christian Bender and Hong Wang. These collaborations have fostered a dynamic environment for innovation and have led to the development of groundbreaking therapies.
Conclusion
In summary, Xi Chen's work in the field of biopharmaceuticals, particularly through his patent and collaborations at Genentech, highlights his significant impact on medical innovation. His contributions continue to pave the way for advancements in targeted therapies.